Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing.

Stanislaw C, Xue Y, Wilcox WR.

Cancer Biol Med. 2016 Mar;13(1):55-67. doi: 10.28092/j.issn.2095-3941.2016.0002.

2.

Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.

Bradbury AR, Patrick-Miller L, Long J, Powers J, Stopfer J, Forman A, Rybak C, Mattie K, Brandt A, Chambers R, Chung WK, Churpek J, Daly MB, Digiovanni L, Farengo-Clark D, Fetzer D, Ganschow P, Grana G, Gulden C, Hall M, Kohler L, Maxwell K, Merrill S, Montgomery S, Mueller R, Nielsen S, Olopade O, Rainey K, Seelaus C, Nathanson KL, Domchek SM.

Genet Med. 2015 Jun;17(6):485-92. doi: 10.1038/gim.2014.134. Epub 2014 Oct 9.

3.

The translational potential of research on the ethical, legal, and social implications of genomics.

Burke W, Appelbaum P, Dame L, Marshall P, Press N, Pyeritz R, Sharp R, Juengst E.

Genet Med. 2015 Jan;17(1):12-20. doi: 10.1038/gim.2014.74. Epub 2014 Jun 19. Review.

4.

Corrected Feedback: A Procedure to Enhance Recall of Informed Consent to Research among Substance Abusing Offenders.

Festinger DS, Dugosh KL, Croft JR, Arabia PL, Marlowe DB.

Ethics Behav. 2010 Jan 1;20(5):387-399.

5.

Ethical considerations in the collection of genetic data from critically ill patients: what do published studies reveal about potential directions for empirical ethics research?

Freeman BD, Kennedy CR, Frankel HL, Clarridge B, Bolcic-Jankovic D, Iverson E, Shehane E, Celious A, Zehnbauer BA, Buchman TG.

Pharmacogenomics J. 2010 Apr;10(2):77-85. doi: 10.1038/tpj.2009.61. Epub 2009 Dec 8.

6.

Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.

Christensen KD, Roberts JS, Royal CD, Fasaye GA, Obisesan T, Cupples LA, Whitehouse PJ, Butson MB, Linnenbringer E, Relkin NR, Farrer L, Cook-Deegan R, Green RC.

Genet Med. 2008 Mar;10(3):207-14. doi: 10.1097/GIM.0b013e318164e4cf.

7.

When research seems like clinical care: a qualitative study of the communication of individual cancer genetic research results.

Miller FA, Giacomini M, Ahern C, Robert JS, de Laat S.

BMC Med Ethics. 2008 Feb 22;9:4. doi: 10.1186/1472-6939-9-4.

8.

Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions.

Green MJ, Peterson SK, Baker MW, Friedman LC, Harper GR, Rubinstein WS, Peters JA, Mauger DT.

Genet Med. 2005 Apr;7(4):221-9.

9.
10.

Research issues in genetic testing of adolescents for obesity.

Segal ME, Sankar P, Reed DR.

Nutr Rev. 2004 Aug;62(8):307-20. Review.

11.
12.

Tailoring communication in consultations with women from high risk breast cancer families.

Lobb EA, Butow PN, Meiser B, Barratt A, Gaff C, Young MA, Kirk J, Suthers GK, Tucker K.

Br J Cancer. 2002 Aug 27;87(5):502-8.

13.

Why should primary care physicians know about breast cancer genetics?

Pinsky LE, Culver JB, Hull J, Levy-Lahad E, Daly M, Burke W.

West J Med. 2001 Sep;175(3):168-73. Review. No abstract available.

14.

High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects.

Goelen G, Teugels E, Bonduelle M, Neyns B, De Grève J.

J Med Genet. 1999 Apr;36(4):304-8.

15.

Missense mutations in disease genes: a Bayesian approach to evaluate causality.

Petersen GM, Parmigiani G, Thomas D.

Am J Hum Genet. 1998 Jun;62(6):1516-24.

Supplemental Content

Support Center